DGX
Quest Diagnostics Incorporated
246.50$
-0.4%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.8% | +0.3% | +2.6% | -2.3% | +2.6% | +22.1% | +14.3% | -8.4% | -6.4% | +6.7% | +11.8% | |
| – | +0.4% | -0.9% | +2.2% | +4.4% | +2.3% | +15.2% | +13.4% | -2.0% | -3.9% | +6.9% | +13.3% | |
| – | +1.4% | +2.2% | +3.1% | -12.9% | +3.2% | +35.1% | +15.9% | -18.4% | -11.1% | +6.3% | +8.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.8% | +0.1% | +4.1% | -18.6% | +2.3% | +6.4% | +11.4% | +5.3% | -1.1% | -1.6% | +8.5% | |
| – | -2.4% | -1.8% | +4.9% | -17.8% | -2.8% | +14.0% | +10.0% | +9.7% | -18.1% | +15.6% | +1.2% | |
| – | +42.3% | -8.7% | -8.8% | -5.5% | +11.8% | +60.1% | +20.8% | -40.0% | -11.6% | +6.7% | +19.1% | |
| – | -8.4% | -6.5% | +7.0% | +10.5% | +6.5% | -7.8% | -8.4% | -2.6% | +2.7% | +48.7% | +22.6% | |
| – | +29.9% | -1.5% | -5.2% | -10.1% | +22.4% | +72.9% | +36.7% | -52.2% | -11.6% | +5.7% | +13.9% | |
| – | +42.4% | +15.0% | -43.8% | -24.5% | +35.7% | +86.2% | +29.8% | -55.8% | -193.9% | – | +15.0% | |
| – | +27.5% | -9.0% | +19.7% | -4.7% | +16.6% | +66.8% | +39.4% | -52.6% | -9.7% | +2.0% | +13.9% | |
| – | +19.2% | -4.9% | -1.8% | -3.4% | +12.9% | +52.1% | +31.0% | -42.4% | -30.7% | +50.1% | +15.8% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.